Biotest AG Pfd. | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR3.88 |
Market Cap |
EUR870.57 M |
Shares Outstanding |
19.79 M |
Public Float |
- |
Biotest AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR3.88 |
Market Cap |
EUR878.49 M |
Shares Outstanding |
19.79 M |
Public Float |
2 M |
Address |
Landsteinerstrasse 5 Dreieich Hessen 63303 Germany |
Employees | - |
Website | http://www.biotest.de |
Updated | 07/08/2019 |
Biotest AG engages in the development and distribution of biological and biotechnological pharmaceutical products. It focuses in the field of clinical immunology, haematology, and intensive care medicine. The company operates through the following segment: Therapy, Plasma & Services, and Other. |